Biography
Ranjan Sen, born in 1967[1] in the Indian state of West Bengal, earned the post-graduate degree of MSc in molecular biology and biophysics in 1991 from the University of Calcutta and did his doctoral studies on the conformational changes of E.coli RNA polymerase during transcription initiation under the guidance of Dipak Dasgupta at the Saha Institute of Nuclear Physics to secure a PhD in 1996.[2] His post-doctoral work was, first at the laboratory of Nobuo Shimamoto of the National Institute of Genetics during 1995–98 and later, with Robert Weisberg at the National Institutes of Health during 1998–2001. On his return to India in 2002, he joined the Centre for DNA Fingerprinting and Diagnostics (CDFD) as a scientist. He continues at the institution, holding the position of a scientist grade IV and heads the Lab of Transcription where he hosts several scientists and scholars.[3] He also serves as the director-in-charge of CDFD.[4]
During his post-doctoral days in Japan, Sen worked on the kinetics of abortive transcription in prokaryotes and proposed the concept of branched pathway during transcription initiation process.[2] While in the US, he furthered his work by focusing on transcription antitermination mechanisms by PUT RNA. At CDFD, the team led by him is involved in the studies of antitermination in prokaryotes, combining physical, chemical, biological and genetic techniques.[5] His studies have been documented by way of a number of articles[6][note 1] and ResearchGate, an online repository of scientific articles has listed 60 of them.[7] He is also a member of the Task Force on Biotechnology set up by the Science and Engineering Research Board of the Department of Science and Technology.[5]
